-
GlaxoSmithKline Sees Staged Roll-Out of Malaria Vaccine
The world's first malaria vaccine, which won a green light last week from European drugs regulators, will be rolled out gradually in Africa, its maker said on Wednesday.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Nigeria’s Ministry of Health Accuses Okonjo-Iweala of Making Questionable Payment to Global Health NGO
ficials of Nigeria’s Federal Ministry of Health (FMOH) are questioning how former Finance Minister Ngozi Okonjo-Iweala handled payment of the sum of $2.2 million that was the subject of a dispute between the Health Ministry and a global non-governmental organization called the Global Alliance for Vaccine and Immunization (GAVI). Former Nigerian Minister of Finance, Ngozi Okonjo-Iweala
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
How Anti-Vaxxers Have Scared the Media Away From Covering Vaccine Side Effects
"It was the most startling side effect I've ever come across." That's how Elizabeth Miller, head of the immunization department at Public Health England, described some recent vaccine research you've probably never heard about: Pandemrix, a shot designed to stave off swine flu, also appears to be causing narcolepsy in some children.
- Categories
- Health Care
- Tags
- public policy, vaccines
-
World’s First Malaria Vaccine Gets Regulatory Go-Ahead, Faces WHO Review
The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it as safe and effective to use in babies in Africa at risk of the mosquito-borne disease.
- Categories
- Health Care
- Tags
- vaccines
-
Trying to Get the World Unhooked From Hookworm
This week, Goats and Soda learned of a pretty icky research experiment taking place in our nation's capital. People are becoming infected with hookworm in the name of science, as researchers seek to develop a vaccine.
- Categories
- Health Care
- Tags
- vaccines
-
Health Specialists Call for $2 Billion Global Fund for Vaccines
Global health experts called on Wednesday for the creation of a $2 billion vaccine development fund to feed a pipeline of potential new shots against priority killer diseases like Ebola, MERS and the West Nile virus.
- Categories
- Health Care
-
Sanofi Preps for ‘Profitable’ Dengue Vaccine Rollout in 20 Countries
With more than $1.5 billion in development costs and 20 years of research on the line, Sanofi ($SNY) is getting revved up to launch its world-first dengue vaccine later this year. And if the company's predictions are correct, the shot will not only be a big deal for patients in the developing world--it'll be a highly profitable product to boot.
- Categories
- Health Care
-
Sanofi Unveils Restructuring Plans, Prunes Business Units
Sanofi’s (SNY - Analyst Report) newly appointed Chief Executive Officer Olivier Brandicourt, after just three months of being at the helm, has made a big move by declaring plans to reorganize its business. Brandicourt intends to restructure the seven existing business units into five global business units. Along with its existing vaccines unit – Sanofi Pasteur – and the animal health business – Merial, the company plans to create three new global business units, namely, General Medicines & Emerging Markets, Specialty Care and Diabetes & Cardiovascular.
- Categories
- Health Care
- Tags
- vaccines
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.